A purple and pink letter v on a white background.
September 24, 2020

What’s Next In Hair Restoration?

 

 While demand for hair restoration solutions has been strong for years, it has been accelerating recently on a global scale. According to a ISHRS survey , the number of people who sought medical treatments to address hair loss increased by 13% between 2016 and 2019. In fact, medical professionals performed 735,312 surgical hair restoration procedures throughout the world in 2019, an increase of 16% from 2016.—while 1,401,589 patients opted for nonsurgical procedures in 2019 , a 13% rise from 2016. The same survey found that the number of hair restoration patients rocketed by 157% between 2008 and 2019 .  

 

These statistics reflect a growing worldwide trend, with no signs of slowing. The most treatments were performed on patients in Asia at 196,630; the Middle East comprised 188,360; and the United States and Canada had 182,025 procedures. While patients in Europe comprised 106,949, this area had the largest growth with an increase of 35% since 2016.

The estimated worldwide market appeal for surgical hair restoration has increased by 10% since 2016 and is now worth $4.6 billion U.S. dollars. The survey also revealed the following:

  • The most common reason for seeking hair restoration was “social/dating,” with 37% of respondents citing this. Another 35% of patients named “career/professional” as their motivation for treatment.
  • While more men proceeded with hair restoration procedures (84.2%), 15.8% of patients were women.
  • The majority of patients who chose hair restoration surgery were in their 30s and 40s.

In addition to hair restoration on the scalp, patients showed a tendency to opt for body hair transplantation. 15% of procedures on men targeted other areas of the body, the most common being near the beard and mustache. Female patients received treatments for non-scalp areas 18% of the time, most frequently by the eyebrows.

Technological Advances Help Drive the Demand  

Advancements in Follicular Unit Extraction (FUE) technologies—such as robotic integration and automation—have positively impacted hair restoration techniques, making it possible to provide patients with more natural-looking results. Cutting-edge hair restoration systems that harness the FUE method include:

  • NeoGraft®: This is one of the first automated FUE systems in the hair restoration market. It eliminates the need for manual extractions and implants, making harvesting, site-making, and implantation easier and more efficient for physicians. Plus, NeoGraft® delivers high levels of patient satisfaction, with an average Real Self score of 95% (+/-) .
  • ARTAS iX™: Advanced technological features on this robotic hair restoration system such as its 7-axis robotic arm and artificial intelligence, make the ARTAS iX™ system a significant advantage to your medical aesthetics clinic, especially if you are an experienced hair restoration surgeon and would like to distinguish your practice as the top-tier provider. Its intuitive controls and programming are helpful tools in improving the physician’s ability to analyze, extract, and implant follicles, resulting in customizable treatments that create natural-looking results without sacrificing patient comfort.

Helping You Meet the Demand for Hair Restoration

The demand for hair restoration treatment continues to rise. Is your practice positioned to capitalize on the trend? Discover how Venus Concept’s VERO Hair™ program makes it easy. VERO Hair™ is a full-service, comprehensive solution  that can help you grow your hair restoration business while delivering natural-looking results for your patients. It combines automated and advanced robotic FUE technologies with extensive  post-sales support tools, including clinical training, marketing toolsbusiness development programs and VeroGrafters™ services.

VERO Hair™ offers the latest in technology, giving you a competitive edge. With a portfolio of robotic and automated FUE  hair restoration systems, you can perform the most advanced, in-demand procedures using our devices. Both systems deliver superior clinical efficacy and high patient satisfaction.

VERO Hair™ includes:

If you are interested in learning more about how VERO Hair™ can complement your clinic’s current offerings, reach out to one of our experts today using the button below.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.